| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.913 | 0.003 | 0.913 | Anticonvulsant | 0.9 0.004 CID_154699886 0.901 0.004 CID_135624512 | ||
| 0.787 | 0.002 | 0.787 | Benzodiazepine agonist | 0.6 0.002 CID_154699886 0.703 0.002 CID_135624512 | ||
| 0.614 | 0.003 | 0.614 | GABA receptor agonist | 0.239 0.011 CID_154699886 0.575 0.003 CID_135624512 | ||
| 0.523 | 0.008 | 0.631 | Platelet aggregation inhibitor | 0.378 0.021 CID_154699886 0.631 0.005 CID_135624512 | CID_135624512 | |
| 0.501 | 0.009 | 0.501 | Sigma receptor agonist | 0.428 0.018 CID_154699886 0.34 0.032 CID_135624512 | ||
| 0.482 | 0.031 | 0.482 | GABA C receptor rho-3 antagonist | 0.374 0.074 CID_154699886 0.405 0.059 CID_135624512 | ||
| 0.467 | 0.039 | 0.567 | Toll-Like receptor 7 agonist | 0.567 0.021 CID_154699886 | CID_154699886 | |
| 0.459 | 0.041 | 0.559 | Toll-Like receptor agonist | 0.559 0.022 CID_154699886 | CID_154699886 | |
| 0.347 | 0.011 | 0.347 | Gastrin inhibitor | 0.24 0.092 CID_154699886 0.257 0.071 CID_135624512 | ||
| 0.327 | 0.009 | 0.414 | Platelet activating factor antagonist | 0.205 0.025 CID_154699886 0.414 0.005 CID_135624512 | CID_135624512 | |
| 0.312 | 0.03 | 0.312 | Anesthetic general | 0.187 0.082 CID_154699886 0.193 0.078 CID_135624512 | ||
| 0.251 | 0.051 | 0.474 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.202 0.075 CID_154699886 0.474 0.008 CID_135624512 | CID_135624512 | |
| 0.194 | 0.005 | 0.194 | GABA A receptor antagonist | 0.178 0.007 CID_135624512 | ||
| 0.193 | 0.006 | 0.193 | GABA receptor antagonist | 0.182 0.007 CID_135624512 | ||
| 0.193 | 0.033 | 0.193 | GABA C receptor rho-2 antagonist | 0.123 0.119 CID_154699886 0.182 0.04 CID_135624512 | ||
| 0.242 | 0.095 | 0.276 | Spasmolytic | 0.276 0.08 CID_154699886 | CID_154699886 | |
| 0.159 | 0.012 | 0.225 | Glutamate (mGluR group I) antagonist | 0.103 0.025 CID_154699886 0.225 0.006 CID_135624512 | CID_135624512 | |
| 0.154 | 0.008 | 0.164 | Alpha 2d adrenoreceptor antagonist | 0.164 0.006 CID_135624512 | CID_135624512 | |
| 0.177 | 0.034 | 0.361 | Glutamate receptor antagonist | 0.141 0.057 CID_154699886 0.361 0.006 CID_135624512 | CID_135624512 | |
| 0.181 | 0.057 | 0.181 | Polo-like kinase-3 inhibitor | 0.177 0.06 CID_154699886 0.178 0.059 CID_135624512 | ||
| 0.127 | 0.006 | 0.127 | Cholecystokinin antagonist | 0.059 0.019 CID_154699886 | ||
| 0.14 | 0.019 | 0.198 | Glutamate (mGluR) antagonist | 0.093 0.039 CID_154699886 0.198 0.01 CID_135624512 | CID_135624512 | |
| 0.125 | 0.005 | 0.125 | Phosphodiesterase VII inhibitor | 0.1 0.013 CID_154699886 0.118 0.007 CID_135624512 | ||
| 0.287 | 0.169 | 0.287 | DNA directed DNA polymerase inhibitor | |||
| 0.204 | 0.091 | 0.258 | Cyclic AMP phosphodiesterase inhibitor | 0.258 0.06 CID_154699886 0.179 0.112 CID_135624512 | CID_154699886 | |
| 0.252 | 0.146 | 0.252 | Immunosuppressant | 0.225 0.171 CID_154699886 | ||
| 0.155 | 0.053 | 0.17 | MAP3K9 inhibitor | 0.139 0.078 CID_154699886 0.17 0.036 CID_135624512 | CID_135624512 | |
| 0.223 | 0.127 | 0.252 | 12-Lipoxygenase inhibitor | 0.252 0.108 CID_135624512 | CID_135624512 | |
| 0.11 | 0.018 | 0.11 | Purinergic P2 antagonist | 0.108 0.018 CID_135624512 | ||
| 0.107 | 0.027 | 0.107 | Phosphodiesterase XI inhibitor | 0.08 0.059 CID_135624512 | ||
| 0.107 | 0.027 | 0.107 | Phosphodiesterase 11A inhibitor | 0.08 0.059 CID_135624512 | ||
| 0.093 | 0.013 | 0.093 | Phosphodiesterase II inhibitor | 0.084 0.016 CID_154699886 0.072 0.022 CID_135624512 | ||
| 0.084 | 0.005 | 0.084 | Phosphodiesterase 7A inhibitor | 0.068 0.013 CID_154699886 0.078 0.007 CID_135624512 | ||
| 0.16 | 0.088 | 0.185 | LIM domain kinase 1 inhibitor | 0.185 0.07 CID_135624512 | CID_135624512 | |
| 0.083 | 0.013 | 0.083 | Phosphodiesterase 2A inhibitor | 0.076 0.015 CID_154699886 0.065 0.021 CID_135624512 | ||
| 0.08 | 0.014 | 0.137 | Glutamate (mGluR5) antagonist | 0.054 0.026 CID_154699886 0.137 0.006 CID_135624512 | CID_135624512 | |
| 0.1 | 0.041 | 0.112 | Interleukin 5 antagonist | 0.112 0.03 CID_154699886 0.106 0.035 CID_135624512 | CID_154699886 | |
| 0.216 | 0.163 | 0.272 | Interleukin 2 agonist | 0.272 0.096 CID_154699886 | CID_154699886 | |
| 0.058 | 0.015 | 0.058 | Benzodiazepine antagonist | 0.044 0.041 CID_135624512 | ||
| 0.155 | 0.112 | 0.29 | Psychostimulant | 0.29 0.045 CID_135624512 | CID_135624512 | |
| 0.141 | 0.099 | 0.172 | Mcl-1 antagonist | 0.172 0.072 CID_135624512 | CID_135624512 | |
| 0.103 | 0.062 | 0.103 | Gastric antisecretory | |||
| 0.066 | 0.035 | 0.077 | Corticotropin releasing factor 2 receptor antagonist | 0.077 0.02 CID_135624512 | CID_135624512 | |
| 0.05 | 0.022 | 0.05 | Phosphodiesterase 6C inhibitor | |||
| 0.064 | 0.036 | 0.145 | Glutamate (mGluR1) antagonist | 0.145 0.007 CID_135624512 | CID_135624512 | |
| 0.06 | 0.032 | 0.06 | Bromodomain-containing protein 4 inhibitor | |||
| 0.12 | 0.095 | 0.125 | CDC-like kinase 1 inhibitor | 0.125 0.09 CID_135624512 | CID_135624512 | |
| 0.038 | 0.016 | 0.038 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.028 CID_154699886 0.034 0.024 CID_135624512 | ||
| 0.091 | 0.076 | 0.095 | GABA C receptor rho-1 antagonist | 0.095 0.069 CID_135624512 | CID_135624512 | |
| 0.189 | 0.176 | 0.189 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.165 | 0.153 | 0.215 | Interleukin agonist | 0.215 0.107 CID_154699886 | CID_154699886 | |
| 0.147 | 0.138 | 0.188 | Potassium channel blocker | 0.188 0.1 CID_154699886 | CID_154699886 | |
| 0.136 | 0.128 | 0.328 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.328 0.035 CID_135624512 | CID_135624512 | |
| 0.12 | 0.113 | 0.127 | Heat shock protein 90 antagonist | 0.127 0.102 CID_135624512 | CID_135624512 | |
| 0.141 | 0.138 | 0.258 | Death-associated protein kinase 3 inhibitor | 0.258 0.05 CID_135624512 | CID_135624512 | |
| 0.123 | 0.122 | 0.146 | Protein kinase (CK1) gamma 3 inhibitor | 0.146 0.094 CID_135624512 | CID_135624512 | |
| 0.01 | 0.011 | 0.013 | Immunosuppressant Cyclosporine-like | 0.013 0.006 CID_154699886 | CID_154699886 | |
| 0.077 | 0.083 | 0.129 | Potassium channel activator | 0.129 0.028 CID_135624512 | CID_135624512 | |
| 0.013 | 0.023 | 0.019 | Purinergic P2T antagonist | 0.019 0.017 CID_135624512 | CID_135624512 | |
| 0.124 | 0.14 | 0.171 | Platelet adhesion inhibitor | 0.171 0.088 CID_135624512 | CID_135624512 | |
| 0.086 | 0.103 | 0.122 | GABA C receptor antagonist | 0.122 0.051 CID_135624512 | CID_135624512 | |
| 0.028 | 0.048 | 0.048 | Dopamine D5 antagonist | 0.048 0.027 CID_135624512 | CID_135624512 | |
| 0.102 | 0.122 | 0.127 | Protein kinase (CK1) gamma 1 inhibitor | 0.127 0.09 CID_135624512 | CID_135624512 | |
| 0.191 | 0.236 | 0.285 | Transcription factor inhibitor | 0.285 0.163 CID_135624512 | CID_135624512 | |
| 0.109 | 0.159 | 0.203 | Clk dual-specificity kinase inhibitor | 0.203 0.078 CID_135624512 | CID_135624512 | |
| 0.075 | 0.135 | 0.18 | Protein kinase (CK1) inhibitor | 0.18 0.048 CID_135624512 | CID_135624512 | |
| 0.063 | 0.135 | 0.083 | DNA directed RNA polymerase inhibitor | 0.083 0.08 CID_135624512 | CID_135624512 | |
| 0.057 | 0.144 | 0.122 | Protein kinase (CK2) alpha inhibitor | 0.122 0.061 CID_135624512 | CID_135624512 | |
| 0.105 | 0.2 | 0.367 | Hypolipemic | 0.367 0.031 CID_154699886 | CID_154699886 | |
| 0.043 | 0.151 | 0.101 | Protein kinase (CK2) inhibitor | 0.101 0.063 CID_135624512 | CID_135624512 | |
| 0.021 | 0.151 | 0.063 | NMDA receptor glycine site agonist | 0.063 0.042 CID_135624512 | CID_135624512 | |
| 0.072 | 0.216 | 0.189 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.189 0.085 CID_135624512 | CID_135624512 | |
| 0.046 | 0.202 | 0.093 | Ferrochelatase inhibitor | 0.093 0.079 CID_154699886 | CID_154699886 | |
| 0.075 | 0.25 | 0.241 | Dyrk kinase inhibitor | 0.241 0.076 CID_135624512 | CID_135624512 | |
| 0.07 | 0.245 | 0.242 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.242 0.071 CID_135624512 | CID_135624512 | |
| 0.04 | 0.222 | 0.17 | Glycogen synthase kinase-3 alpha inhibitor | 0.17 0.053 CID_135624512 | CID_135624512 | |
| 0.05 | 0.263 | 0.133 | CDC-like kinase 4 inhibitor | 0.133 0.115 CID_135624512 | CID_135624512 | |
| 0.06 | 0.277 | 0.12 | Cell wall synthesis inhibitor | 0.12 0.099 CID_154699886 | CID_154699886 | |
| 0.081 | 0.302 | 0.238 | Prostaglandin dehydrogenase inhibitor | 0.238 0.133 CID_135624512 | CID_135624512 | |
| 0.103 | 0.408 | 0.177 | Peptidyltransferase inhibitor | 0.177 0.134 CID_154699886 | CID_154699886 | |
| 0.104 | 0.415 | 0.244 | Analgesic | 0.244 0.188 CID_154699886 | CID_154699886 | |
| 0.082 | 0.415 | 0.368 | Antiobesity | 0.368 0.079 CID_154699886 0.297 0.118 CID_135624512 | CID_154699886 | |
| 0.01 | 0.398 | 0.068 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.068 0.063 CID_135624512 | CID_135624512 | |
| 0.023 | 0.44 | 0.141 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.141 0.084 CID_135624512 | CID_135624512 | |
| 0.05 | 0.637 | 0.337 | Cyclophilin D inhibitor | 0.337 0.132 CID_154699886 0.257 0.205 CID_135624512 | CID_154699886 | |
| 0.072 | 0.797 | 0.309 | Calcium channel L-type activator | 0.309 0.15 CID_154699886 | CID_154699886 | |
| 0.008 | 0.733 | 0.1 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 CID_154699886 | CID_154699886 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |